Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0RRKPX
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
Cetuximab-IRDye800-AF647
|
|||||
| Synonyms |
Cetuximab-IRDye800-AF647; Cet-IRDye-AF
Click to Show/Hide
|
|||||
| Organization |
Massachusetts General Hospital; Harvard Medical School; Tufts University; Massachusetts Institute of Technology.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.87; 0.87
|
|||||
| Structure |
|
|||||
| Antibody Name |
Cetuximab
|
Antibody Info | ||||
| Antigen Name |
Epidermal growth factor receptor (EGFR)
|
Antigen Info | ||||
| Payload Name |
IRDye800CW
|
Payload Info | ||||
| Payload Name |
AF647
|
Payload Info | ||||
| Linker Name |
Undisclosed
|
|||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteine.
|
|||||